pharmaphorum

MAY 20, 2022

The earlier draft guidance showed that NICE was uncertain whether Sleepio would save money for the NHS, but its latest document recommends the app as a cost-saving option for treating insomnia in primary care “for people who would otherwise be offered advice about sleep hygiene or sleeping pills.”

Documentation 120

Documentation 120

Pharmacy Times

APRIL 14, 2023

41% of patients report moderate-to-severe issues, with Black individuals 3 times more likely to develop these difficulties.

49

49

pharmaphorum

JUNE 8, 2022

Sleep and its importance to health is becoming a greater focus of research. With more research being published, the public is becoming more aware of sleep’s functions and there are a number of apps and devices that now allow users to gauge the quality of their rest. There are few things more important to good health than sleep.

Compounding 98

Compounding Diabetes Drug Development 98

RX Note

JANUARY 29, 2024

Introduction Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WEB), is a common sleep-related movement disorder characterized by an often unpleasant or uncomfortable urge to move the legs that occurs during periods of inactivity , particularly in the evenings and is transiently relieved by movement.

Mayo Clinic 52

Mayo Clinic Diabetes 52

pharmaphorum

JUNE 8, 2022

Users can also use the built-in health records feature on the Health app to download current medications, said Ricky Bloomfield, a former director of mobile strategy at Duke University who joined Apple as clinical and health informatics lead in 2016 in a tweet. REM, core and deep sleep – using machine learning techniques.

Documentation 130

Documentation Labelling 130

pharmaphorum

MARCH 12, 2021

Sleep disturbances are a common feature for people with Parkinson’s disease, and a device developed to help people with insomnia is now being trialled to see if it can improve their sleep quality. . If successful, the pilot could be followed by a clinical trial programme, according to the partners.

Compounding 125

Compounding Communication 125

Pharmaceutical Technology

MAY 4, 2023

It blocks only the orexin receptors activation that promote wakefulness, rather than inducing sleep through broad inhibition of brain activity (sedation). This therapy decreases the over-active wake drive for patients with insomnia and allows sleep to occur, without interfering with the stages of sleep.

52

52

pharmaphorum

JANUARY 25, 2022

The UK company behind a sleep mask that aims to treat sight-robbing complications of diabetes has secured $10 million in funding that will be used to run trials of the medical device. The new clinical trials made possible by the new funding “will open the US market to the treatment,” said the company in a statement.

Diabetes 108

Diabetes Hospitals 108

Pharma Mirror

SEPTEMBER 16, 2022

Barcelon, a global biopharmaceutical company focused on skin health, announced at the 31st EADV (European Association of Dermatology and Venereology) Congress the results from TRIBUTE, an interventional phase IV clinical study, which resembled real-life clinical practice. In this study, Ilumetri®?

52

52

Pharmaceutical Technology

JUNE 13, 2023

Quviviq is a dual orexin receptor antagonist that blocks the orexin receptors’ activation, which leads to wakefulness, instead of inducing sleep through broad inhibition of brain activity (sedation). It decreases the wake drive and allows sleep to occur, without changing the stages of sleep.

Adverse Reactions 52

Adverse Reactions 52

Pharmaceutical Business Review

SEPTEMBER 17, 2023

Idorsia UK general manager Robert Moore said: “We are delighted that NICE has acknowledged the clinical benefits and value that this new treatment can offer to the eligible patient population with chronic insomnia. The post UK’s NICE recommends QUVIVIQ to treat chronic insomnia in adults appeared first on Pharmaceutical Business review.

98

98

pharmaphorum

DECEMBER 14, 2022

Wake up and go to sleep. The irony of these two narcolepsy drugs that work to normalise the sleep-wake cycle is that they have to be taken twice per night. Patients have the first dose before they go to sleep, then wake up two and a half to four hours later for the second. Pulling an all-nighter. Monopoly money.

Controlled Substances 114

Controlled Substances 114

FADIC

AUGUST 12, 2023

Throughout history, many of the great minds have turned to short bouts of sleep to refresh their thoughts and reset their minds. Anything more than 30 minutes might put you into REM sleep, which can result in sleep inertia, that feeling of grogginess and disorientation upon waking. What do these icons of history have in common?

97

97

Pharmaceutical Technology

JANUARY 24, 2024

PXS-4728 is under clinical development by Syntara and currently in Phase II for Sleep Disorders.

40

40

pharmaphorum

MAY 6, 2022

A digital therapeutic (DTx) developed to help people suffering from insomnia has been shown to improve sleep and mental health in people recovering from a stroke in a clinical trial. The use of the Sleepio app improved sleep quality in 48% of patients enrolled into the study, which was conducted with the University of Oxford.

52

52

Outsourcing Pharma

MARCH 2, 2021

The Verisense Pulse+ can measure heart rate, oxygen saturation, emotional responses, and activity and sleep levels of at-home clinical trial participants.

79

79

Board Vitals - Pharmacist

JANUARY 24, 2024

Sleep Medicine The biennial Sleep Medicine board exam saw an increase in pass rates, going from 88% in 2021 to 94% in 2023. Success in the exams is contingent on a comprehensive understanding of the material, critical thinking skills, and the ability to apply knowledge in diverse clinical scenarios. What Do the Pass Rates Mean?

101

101

STAT

JANUARY 4, 2023

Balmy breezes and clear blue skies are enveloping the Pharmalot campus, where the official mascot is eagerly awaiting his first constitutional of the day and the short person is sleeping in.

Health and Personal Care Stores 130

Health and Personal Care Stores Mail-Order Pharmacies 130

ALiEM - Pharm Pearls

NOVEMBER 27, 2023

A 24-year-old G1P0010 female with a PMHx of ovarian cyst (unknown laterality) and emergency contraceptive use 3 months prior presented with sudden onset abdominal pain (upper > lower) that awoke her from sleep four hours prior to presentation with associated nausea and mild lower back pain. The pain is 10/10, sharp, stabbing, and diffuse.

158

158

PharmaShots

MARCH 20, 2023

clinical improvement in itch intensity as defined by a 4-point improvement in PP-NRS (41.0% vs 7.7%) & sleep disturbance as measured by a 4-point improvement in SD-NRS (37.2% vs 9.9%) The safety profile was consistent with the P-II trial results.

40

40

pharmaphorum

AUGUST 21, 2020

The pilot study of the app – which combines physical therapy, relaxation exercises and medical information to help back pain sufferers manage their condition – showed it was able to reduce self-reported pain and sleep quality. Looking at the whole study group, the average pain reduction was 35%, with a 59% improvement in sleep.

128

128

Pharmafile

MARCH 31, 2023

Published date: 31/03/2023 Summary: • Lebrikizumab is a novel monoclonal antibody that binds to IL-13 with high affinity and prevents its downstream signaling with high potency • The NEJM manuscript reports Week 16 efficacy and safety data from ADvocate1 and ADvocate2, two identically designed Phase 3 monotherapy studies in adults and adolescents with (..)

52

52

pharmaphorum

SEPTEMBER 7, 2021

. “This evaluation revealed significant value in introducing an evidence-based digital sleep intervention at scale within a clinical mental health service,” they conclude. However, most patients are either given medications or placed on a long waiting list for therapy.

62

62

Amber

AUGUST 11, 2022

No matter the specialty, clinic size, or type of health system, both roles are susceptible. Consider Sleep Hygiene an Investment In order to set yourself up for success, you have to start with the basics. Research shows that nurses who get 6 hours of sleep or less nearly triple the risk of making an error.

Specialty Pharmacies 52

Specialty Pharmacies Medical Schools Hospitals 52

pharmaphorum

JULY 26, 2022

According to Big health, randomised controlled trials have shown that 71% of patients who used Daylight achieved a reduction in anxiety, while 76% of Sleepio users achieved clinical improvement in sleep.

134

134

pharmaphorum

AUGUST 24, 2021

million in first-round financing, which it will use to scale up its clinical tool that it says helps people “prevent, manage and reverse type 2 diabetes.” change in HbA1c is considered clinically significant. Digital health startup Breathe Well-being has raised $5.5 That is a remarkable finding, considering a 0.5%

Diabetes 125

Diabetes 125

Dr. Neal Smoller

MARCH 24, 2023

Is CBD the all-in-one anxiety buster, sleep supporter, and pain reducer it’s touted to be? Listen on Spotify | Listen on Apple Podcasts | Listen on Google In This Episode CBD is the supplement industry’s latest unicorn — magical, mysterious, and surrounded by hype. But what’s real and what’s not?

Dosage 52

Dosage Labelling 52

The Thyroid Pharmacist

APRIL 5, 2023

Before the birth of our son, my husband used to jump out of bed and would do a run or hike outside before I woke up, yet after the birth of our son, he was sleeping into the late afternoon and was too exhausted to care for a newborn. Sleeping for ten to twelve hours each night for two to four weeks? I think most new parents can relate.

Immunity 55

Immunity Immunization 55

LifeProNow

MAY 17, 2023

In both studies, patients who received 2 mg or 3 mg of Rexulti showed statistically significant and clinically meaningful improvements in total CMAI scores compared to patients in the placebo group at week 12. The recommended starting dosage for the treatment of agitation associated with dementia due to Alzheimer’s disease is 0.5

Dosage 130

Dosage Nursing Homes Assisted Living Pharmaceutical Companies 130

RX Note

JUNE 18, 2023

Summary Keen, committed and reliable pharmacist with a passion for applying and sharing clinical knowledge. Hobbies Find solace in quality sleep to maintain physical and mental well-being. Proven ability to summarize reading material into clear and concise notes, coupled with a strong interest in information technology and photography.

Hospitals 52

Hospitals 52

European Pharmaceutical Review

OCTOBER 13, 2022

Astellas will present results from a Phase III clinical study evaluating fezolinetant, an investigational oral, non-hormonal compound being studied to potentially treat vasomotor symptoms (VMS) associated with menopause. Fezolinetant is designed as a selective neurokinin 3 (NK3) receptor antagonist.

Compounding 92

Compounding 92

PharmaShots

FEBRUARY 9, 2023

itch-related QoL and itch-related sleep measures, was generally well tolerated The company has completed a P-II PoC trial of difelikefalin for mod. WI-NRS score @8wk., the proportion of patients achieved a ≥4-point improvement in WI-NRS score @8wk. (41% 41% vs 18%), CR (22% vs 5%). The secondary outcomes incl.

40

40

The Thyroid Pharmacist

DECEMBER 15, 2023

Many moons ago, I was chronically exhausted and needed to sleep for 11 to 12 hours to feel human. The medication did reduce my cold intolerance, need for sleep by about one hour, and anxiety. When I first became chronically exhausted, I would sleep as long as possible. I would sleep all day, then stay up all night to study.

Immunity 98

Immunity Immunization Dosage 98

Med Ed 101

MARCH 3, 2021

Obesity is a major risk factor for many comorbidities (hypertension, dyslipidemia, osteoarthritis, sleep apnea, heart disease, type 2 diabetes) and increases all-cause and cardiovascular mortality. The post Medications For Weight Loss – Clinical Breakdown appeared first on Med Ed 101. Medications for […].

Diabetes 40

Diabetes 40

pharmaphorum

AUGUST 12, 2020

While using the Flow headset, patients engaged with a therapy app program, which offers personalised behavioural therapy in areas proven to reduce symptoms of depression, including nutrition, exercise and sleep. Meanwhile 32% of patients reported a reduction in anxiety and 29% reported a reduction in suicidal thoughts.

115

115

European Pharmaceutical Review

OCTOBER 17, 2022

Denise Barbut, Co-Founder, President and CMO of Enterin explained that symptoms associated with PD, “such as gastrointestinal dysfunction, dementia, psychosis, sleep architecture and circadian rhythm,” were positively impacted by the drug in previous studies.

Drug Development 92

Drug Development 92

pharmaphorum

DECEMBER 16, 2022

Sio Gene Therapies’ litany of clinical disappointments over the last few years has finally led to the demise of the biotech, formerly known as Axovant and one of the ‘vant’ companies originally founded by entrepreneur Vivek Ramaswamy.

57

57